The liver is the commonest site of metastatic disease for patients with colorectal cancer, with
at least 25% developing colorectal liver metastases (CRLM) during the course of their …

Rhenium-188 (188Re) is a high energy beta-emitting radioisotope with a short 16.9 h
physical half-life, which has been shown to be a very attractive candidate for use in …

OBJECTIVE. This article reviews recent developments in targeted radionuclide therapy
(TRT) approaches directed to malignant liver lesions, bone metastases, neuroendocrine …

Liver malignancies, either primary tumours (mainly hepatocellular carcinoma and
cholangiocarcinoma) or secondary hepatic metastases, are a major cause of death, with an …

This review provides a comprehensive analysis of the rare earth elements (REEs) sector,
encompassing their classification, properties, and global distribution, as well as their …

In recent decades, the use of alpha; pure beta; or beta/gamma emitters in oncology,
endocrinology, and interventional cardiology rheumatology, has proved to be an important …

The management of metastatic colon and rectal cancer has undergone significant evolution
over the last few decades. Due to advancements in chemotherapy, surgical techniques, and …

A paradigm shift is underway in cancer diagnosis and therapy using radioactivity-based
agents called radiopharmaceuticals. In the new strategy, diagnostic imaging measures the …

OBJECTIVE. The purpose of this study is to discuss the imaging modalities and response
criteria used for assessing hepatocellular carcinoma (HCC) response to 90Y …

Selective internal radiation therapy (SIRT) as one of the radiotherapeutic techniques has
been widely used in the treatment of primary and metastatic liver cancer, for better avoiding …